Madrigal Pharmaceuticals (MDGL) Stock Forecast & Price Target

MDGL$427.39+2.18 +0.51%
BiotechnologyGrowth Stock
Compare
Market cap$9.93BEnterprise value$9.09BRevenue (TTM)$1.43BMarket position—

Score

65
Bullish
Value
50
Quality
44
Growth
100

Madrigal Pharmaceuticals, Inc. price target

MDGL
Low$542.00
Average$684.80
High$962.00
Upside vs current price+60.2%

The average target of $684.80 is +60.2% versus the current MDGL price of $427.39.

Madrigal Pharmaceuticals, Inc. analyst ratings

RatingAnalysts
Strong buy3
Buy15
Hold1
Sell0
Strong sell0
ConsensusBuy

19 analysts cover MDGL.

Madrigal Pharmaceuticals, Inc. EPS and revenue estimates

The estimate table for the Madrigal Pharmaceuticals, Inc. keeps 2026 EPS $-2.75, 2027 EPS $6.82, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-2.75$1.57B
2027$6.82$2.17B

Is Madrigal Pharmaceuticals, Inc. a buy or sell?

Of the 19 analysts covering Madrigal Pharmaceuticals, Inc., 18 rate it a buy (3 strong buy and 15 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The MDGL consensus label is Buy, beside 18 buy-side ratings and 0 sell-side ratings.

The average target of $684.80 implies +60.2% versus the current price of $427.39.

the Madrigal Pharmaceuticals, Inc. closes with 18 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Madrigal Pharmaceuticals, Inc. forecast

Analysts are far apart on MDGL. The published low is $542.00, the average is $684.80, and the high is $962.00.

From today's $427.39 print, the MDGL average target is +60.2% away.

Most of the MDGL coverage agrees: 18 of 19 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

MDGL has both upgrades (1) and downgrades (0) in the recent window.

The MDGL average target is little changed, $702.50 over the last month and $703.00 over the last quarter.

Coverage of MDGL is broad at 19 analysts, and the average is a crowd rather than a single desk.

Madrigal Pharmaceuticals, Inc. forecast questions

What is the MDGL price target?

The published range for MDGL is $542.00 to $962.00, with an average of $684.80. That average is +60.2% versus the current price of $427.39.

Is Madrigal Pharmaceuticals, Inc. a buy or sell?

Of the 19 analysts covering Madrigal Pharmaceuticals, Inc., 18 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, which for MDGL is 18 on the buy side, 1 at hold, and 0 on the sell side.

What is the EPS estimate for Madrigal Pharmaceuticals, Inc.?

Analyst EPS estimates for Madrigal Pharmaceuticals, Inc.: 2026 $-2.75, 2027 $6.82.

What is the revenue estimate for Madrigal Pharmaceuticals, Inc.?

Analyst revenue estimates for Madrigal Pharmaceuticals, Inc.: 2026 $1.57B, 2027 $2.17B.

How many analysts cover MDGL?

19 analysts cover MDGL. Their consensus on MDGL is Buy, across those 19.

MDGL price $427.39 +2.18 +0.51%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener